Below is a detailed analysis of the quarterly data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 992.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,248.00 Cr. (Dec 2024) to 992.00 Cr., marking a decrease of 256.00 Cr..
For Expenses, as of Mar 2025, the value is 782.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 877.00 Cr. (Dec 2024) to 782.00 Cr., marking a decrease of 95.00 Cr..
For Operating Profit, as of Mar 2025, the value is 210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 371.00 Cr. (Dec 2024) to 210.00 Cr., marking a decrease of 161.00 Cr..
For OPM %, as of Mar 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 30.00% (Dec 2024) to 21.00%, marking a decrease of 9.00%.
For Other Income, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Dec 2024) to 19.00 Cr., marking an increase of 9.00 Cr..
For Interest, as of Mar 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 10.00 Cr..
For Profit before tax, as of Mar 2025, the value is 213.00 Cr.. The value appears to be declining and may need further review. It has decreased from 364.00 Cr. (Dec 2024) to 213.00 Cr., marking a decrease of 151.00 Cr..
For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Dec 2024) to 27.00%, marking an increase of 1.00%.
For Net Profit, as of Mar 2025, the value is 156.00 Cr.. The value appears to be declining and may need further review. It has decreased from 269.00 Cr. (Dec 2024) to 156.00 Cr., marking a decrease of 113.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 48.09. The value appears to be declining and may need further review. It has decreased from 82.74 (Dec 2024) to 48.09, marking a decrease of 34.65.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:28 pm
Metric
Jun 2013
Jun 2014
Jun 2015
Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
TTM
Sales
1,677
2,051
2,334
2,275
2,320
2,455
2,947
3,002
3,574
3,901
3,918
4,206
4,317
Expenses
1,420
1,628
1,838
1,667
1,646
1,834
2,329
2,396
2,688
3,069
3,048
3,230
3,280
Operating Profit
256
423
495
608
675
622
618
606
886
832
869
976
1,037
OPM %
15%
21%
21%
27%
29%
25%
21%
20%
25%
21%
22%
23%
24%
Other Income
61
78
64
85
67
18
45
42
38
23
40
47
39
Interest
0
5
6
6
10
5
5
6
6
11
11
27
31
Depreciation
31
35
53
52
60
52
50
48
48
53
58
56
50
Profit before tax
286
460
501
636
672
582
607
594
870
790
839
939
996
Tax %
29%
34%
31%
34%
36%
36%
31%
27%
25%
27%
19%
28%
Net Profit
203
302
346
422
433
375
419
433
652
576
678
675
716
EPS in Rs
62.60
93.04
106.63
130.16
133.31
115.40
129.12
133.42
200.79
177.37
208.91
207.95
220.55
Dividend Payout %
40%
30%
28%
28%
292%
35%
68%
79%
157%
90%
89%
123%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)
No data available for trend analysis.
Growth
Compounded Sales Growth
10 Years:
7%
5 Years:
7%
3 Years:
6%
TTM:
4%
Compounded Profit Growth
10 Years:
8%
5 Years:
10%
3 Years:
1%
TTM:
-4%
Stock Price CAGR
10 Years:
8%
5 Years:
6%
3 Years:
0%
1 Year:
-20%
Return on Equity
10 Years:
53%
5 Years:
69%
3 Years:
80%
Last Year:
79%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Procter & Gamble Hygiene and Health Care Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Jun 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 23) which recorded 10.00.
For Basic EPS (Rs.), as of Jun 24, the value is 207.95. This value is within the healthy range. It has decreased from 208.91 (Jun 23) to 207.95, marking a decrease of 0.96.
For Diluted EPS (Rs.), as of Jun 24, the value is 207.95. This value is within the healthy range. It has decreased from 208.91 (Jun 23) to 207.95, marking a decrease of 0.96.
For Cash EPS (Rs.), as of Jun 24, the value is 225.36. This value is within the healthy range. It has decreased from 226.89 (Jun 23) to 225.36, marking a decrease of 1.53.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Jun 24, the value is 238.71. It has decreased from 291.44 (Jun 23) to 238.71, marking a decrease of 52.73.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Jun 24, the value is 238.71. It has decreased from 291.44 (Jun 23) to 238.71, marking a decrease of 52.73.
For Dividend / Share (Rs.), as of Jun 24, the value is 255.00. This value exceeds the healthy maximum of 3. It has increased from 185.00 (Jun 23) to 255.00, marking an increase of 70.00.
For Revenue From Operations / Share (Rs.), as of Jun 24, the value is 1,295.66. It has increased from 1,206.99 (Jun 23) to 1,295.66, marking an increase of 88.67.
For PBDIT / Share (Rs.), as of Jun 24, the value is 315.00. This value is within the healthy range. It has increased from 280.10 (Jun 23) to 315.00, marking an increase of 34.90.
For PBIT / Share (Rs.), as of Jun 24, the value is 297.59. This value is within the healthy range. It has increased from 262.12 (Jun 23) to 297.59, marking an increase of 35.47.
For PBT / Share (Rs.), as of Jun 24, the value is 289.34. This value is within the healthy range. It has increased from 258.62 (Jun 23) to 289.34, marking an increase of 30.72.
For Net Profit / Share (Rs.), as of Jun 24, the value is 207.95. This value is within the healthy range. It has decreased from 208.91 (Jun 23) to 207.95, marking a decrease of 0.96.
For PBDIT Margin (%), as of Jun 24, the value is 24.31. This value is within the healthy range. It has increased from 23.20 (Jun 23) to 24.31, marking an increase of 1.11.
For PBIT Margin (%), as of Jun 24, the value is 22.96. This value exceeds the healthy maximum of 20. It has increased from 21.71 (Jun 23) to 22.96, marking an increase of 1.25.
For PBT Margin (%), as of Jun 24, the value is 22.33. This value is within the healthy range. It has increased from 21.42 (Jun 23) to 22.33, marking an increase of 0.91.
For Net Profit Margin (%), as of Jun 24, the value is 16.05. This value exceeds the healthy maximum of 10. It has decreased from 17.30 (Jun 23) to 16.05, marking a decrease of 1.25.
For Return on Networth / Equity (%), as of Jun 24, the value is 87.11. This value is within the healthy range. It has increased from 71.68 (Jun 23) to 87.11, marking an increase of 15.43.
For Return on Capital Employeed (%), as of Jun 24, the value is 110.03. This value is within the healthy range. It has increased from 80.85 (Jun 23) to 110.03, marking an increase of 29.18.
For Return On Assets (%), as of Jun 24, the value is 36.31. This value is within the healthy range. It has increased from 31.72 (Jun 23) to 36.31, marking an increase of 4.59.
For Asset Turnover Ratio (%), as of Jun 24, the value is 2.11. It has increased from 2.05 (Jun 23) to 2.11, marking an increase of 0.06.
For Current Ratio (X), as of Jun 24, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Jun 23) to 1.22, marking a decrease of 0.16.
For Quick Ratio (X), as of Jun 24, the value is 0.99. This value is below the healthy minimum of 1. It has decreased from 1.18 (Jun 23) to 0.99, marking a decrease of 0.19.
For Inventory Turnover Ratio (X), as of Jun 24, the value is 3.47. This value is below the healthy minimum of 4. It has decreased from 3.74 (Jun 23) to 3.47, marking a decrease of 0.27.
For Dividend Payout Ratio (NP) (%), as of Jun 24, the value is 127.43. This value exceeds the healthy maximum of 50. It has increased from 69.40 (Jun 23) to 127.43, marking an increase of 58.03.
For Dividend Payout Ratio (CP) (%), as of Jun 24, the value is 117.59. This value exceeds the healthy maximum of 50. It has increased from 63.90 (Jun 23) to 117.59, marking an increase of 53.69.
For Earning Retention Ratio (%), as of Jun 24, the value is -27.43. This value is below the healthy minimum of 40. It has decreased from 30.60 (Jun 23) to -27.43, marking a decrease of 58.03.
For Cash Earning Retention Ratio (%), as of Jun 24, the value is -17.59. This value is below the healthy minimum of 40. It has decreased from 36.10 (Jun 23) to -17.59, marking a decrease of 53.69.
For Interest Coverage Ratio (X), as of Jun 24, the value is 38.18. This value is within the healthy range. It has decreased from 79.90 (Jun 23) to 38.18, marking a decrease of 41.72.
For Interest Coverage Ratio (Post Tax) (X), as of Jun 24, the value is 26.21. This value is within the healthy range. It has decreased from 60.59 (Jun 23) to 26.21, marking a decrease of 34.38.
For Enterprise Value (Cr.), as of Jun 24, the value is 53,361.78. It has increased from 45,454.09 (Jun 23) to 53,361.78, marking an increase of 7,907.69.
For EV / Net Operating Revenue (X), as of Jun 24, the value is 12.69. This value exceeds the healthy maximum of 3. It has increased from 11.60 (Jun 23) to 12.69, marking an increase of 1.09.
For EV / EBITDA (X), as of Jun 24, the value is 52.19. This value exceeds the healthy maximum of 15. It has increased from 49.99 (Jun 23) to 52.19, marking an increase of 2.20.
For MarketCap / Net Operating Revenue (X), as of Jun 24, the value is 12.83. This value exceeds the healthy maximum of 3. It has increased from 11.85 (Jun 23) to 12.83, marking an increase of 0.98.
For Retention Ratios (%), as of Jun 24, the value is -27.43. This value is below the healthy minimum of 30. It has decreased from 30.59 (Jun 23) to -27.43, marking a decrease of 58.02.
For Price / BV (X), as of Jun 24, the value is 69.63. This value exceeds the healthy maximum of 3. It has increased from 49.08 (Jun 23) to 69.63, marking an increase of 20.55.
For Price / Net Operating Revenue (X), as of Jun 24, the value is 12.83. This value exceeds the healthy maximum of 3. It has increased from 11.85 (Jun 23) to 12.83, marking an increase of 0.98.
For EarningsYield, as of Jun 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Procter & Gamble Hygiene and Health Care Ltd as of June 13, 2025 is: 8,852.42
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 13, 2025, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 34.16% compared to the current share price 13,446.00
Intrinsic Value of Procter & Gamble Hygiene and Health Care Ltd as of June 13, 2025 is: 9,020.18
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 13, 2025, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 32.92% compared to the current share price 13,446.00
Last 5 Year EPS CAGR: 1.90%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Procter & Gamble Hygiene and Health Care Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 87.11% (Industry Average ROE: 24.58%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 60.9 (Industry average Stock P/E: 55.47)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971. Currently Company is involved in the business activities of Manufacture of wadding of textile materials and articles of wadding such as sanitary napkins and tampoons. Company's Total Operating Revenue is Rs. 3374.42 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 31/03/2025.
INDUSTRY
ADDRESS
CONTACT
Personal Care
P & G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Hygiene and Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
